Search Media Items

Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, and corticosteroids. Learn more about the treatment of newly diagnosed and recurrent primary CNS lymphoma cancer in this expert-reviewed summary.

Retinoblastoma treatment may include cryosurgery, laser therapy (thermotherapy), chemotherapy, radiation therapy, high-dose chemotherapy with stem cell rescue, and sometimes surgery. Learn more about newly diagnosed and recurrent retinoblastoma in this expert-reviewed summary.

Plasma cell neoplasms (including multiple myeloma) treatment include observation, chemotherapy, radiation, stem cell rescue, targeted, and supportive therapies. Corticosteroids and immunomodulatory drugs may be used. Get detailed treatment information in this summary for clinicians.

Cervical cancer screening tests (e.g., the Papanicolaou (Pap) Test, HPV DNA, Thin-prep) find cervical changes before cancer develops. Learn more about the potential benefits and harms of these tests in this expert-reviewed summary.

Expert-reviewed information summary about the treatment of small intestine cancer.

Cardiopulmonary syndromes (dyspnea, chronic cough, pleural and pericardial effusion, and superior vena cava syndrome) can occur in certain cancers. Get comprehensive information about these syndromes in this summary for clinicians.

While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 3 and 4.

A summary of clinical trial results showing that daratumumab plus lenalidomide and dexamethasone improved progression-free survival for patients with relapsed or refractory disease.

NCI and FDA collaborate to train physicians in aspects of drug, biologic, or device development and standards for assessing medical product safety. Learn more about this cancer training program.

Learn about the different types of costs related to taking part in a clinical trial, who is expected to pay for which costs, and tips for working with insurance companies.